TY - JOUR AU - Walboomers, J. M. AU - Jacobs, M. V. AU - Manos, M. M. AU - Bosch, F. X. AU - Kummer, J. A. AU - Shah, K. V. AU - Snijders, P. J. AU - Peto, J. AU - Meijer, C. J. AU - Munoz, N. PY - 1999 DA - 1999// TI - Human papillomavirus is a necessary cause of invasive cervical cancer worldwide JO - J Pathol VL - 189 UR - https://doi.org/3.0.CO;2-F DO - 3.0.CO;2-F ID - Walboomers1999 ER - TY - JOUR AU - Smith, J. S. AU - Lindsay, L. AU - Hoots, B. AU - Keys, J. AU - Franceschi, S. AU - Winer, R. AU - Clifford, G. M. PY - 2007 DA - 2007// TI - Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update JO - Int J Cancer VL - 121 UR - https://doi.org/10.1002/ijc.22527 DO - 10.1002/ijc.22527 ID - Smith2007 ER - TY - JOUR AU - La Torre, G. AU - de Waure, C. AU - Chiaradia, G. AU - Mannocci, A. AU - Ricciardi, W. PY - 2007 DA - 2007// TI - HPV vaccine efficacy in preventing persistent cervical HPV infection: a systematic review and meta-analysis JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.09.027 DO - 10.1016/j.vaccine.2007.09.027 ID - La Torre2007 ER - TY - JOUR AU - Rambout, L. AU - Hopkins, L. AU - Hutton, B. AU - Fergusson, D. PY - 2007 DA - 2007// TI - Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials JO - CMAJ VL - 177 UR - https://doi.org/10.1503/cmaj.070948 DO - 10.1503/cmaj.070948 ID - Rambout2007 ER - TY - JOUR AU - La Torre, G. AU - Chiaradia, G. AU - de Waure, C. AU - Nicolotti, N. AU - Monteduro, A. AU - Ricciardi, W. PY - 2009 DA - 2009// TI - Report HTA del vaccino quadrivalente anti-HPV Gardasil (HTA report on quadrivalent HPV vaccine) JO - Ital J Public Health VL - 6 ID - La Torre2009 ER - TY - JOUR AU - La Torre, G. AU - de Waure, C. AU - Chiaradia, G. AU - Mannocci, A. AU - Capri, S. AU - Ricciardi, W. PY - 2010 DA - 2010// TI - The Health Technology Assessment of bivalent HPV vaccine Cervarix in Italy JO - Vaccine VL - 28 UR - https://doi.org/10.1016/j.vaccine.2010.02.080 DO - 10.1016/j.vaccine.2010.02.080 ID - La Torre2010 ER - TY - STD TI - Human papillomaviruses. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer. 2007, 90: 1-636. ID - ref7 ER - TY - JOUR AU - Harper, D. M. AU - Franco, E. L. AU - Wheeler, C. AU - Ferris, D. G. AU - Jenkins, D. AU - Schuind, A. AU - Zahaf, T. AU - Innis, B. AU - Naud, P. AU - De Carvalho, N. S. PY - 2004 DA - 2004// TI - Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)17398-4 DO - 10.1016/S0140-6736(04)17398-4 ID - Harper2004 ER - TY - JOUR AU - Harper, D. M. AU - Franco, E. L. AU - Wheeler, C. M. AU - Moscicki, A. B. AU - Romanowski, B. AU - Roteli-Martins, C. M. AU - Jenkins, D. AU - Schuind, A. AU - Costa Clemens, S. A. AU - Dubin, G. PY - 2006 DA - 2006// TI - Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial JO - Lancet VL - 367 UR - https://doi.org/10.1016/S0140-6736(06)68439-0 DO - 10.1016/S0140-6736(06)68439-0 ID - Harper2006 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. AU - Deeks, J. J. AU - Altman, D. G. PY - 2003 DA - 2003// TI - Measuring inconsistency in meta-analyses JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7414.557 DO - 10.1136/bmj.327.7414.557 ID - Higgins2003 ER - TY - JOUR AU - Begg, C. B. AU - Mazumdar, M. PY - 1994 DA - 1994// TI - Operating Characteristics of a Rank Correlation Test for Publication Bias JO - Biometrics VL - 50 UR - https://doi.org/10.2307/2533446 DO - 10.2307/2533446 ID - Begg1994 ER - TY - JOUR AU - Egger, M. AU - Davey Smith, G. AU - Schneider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - Bmj VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - CHAP PY - 2009 DA - 2009// BT - Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] ID - ref13 ER - TY - STD TI - Review Manager (RevMan). 2008, Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration, 5.0 ID - ref14 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. AU - Altman, D. G. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b2535 DO - 10.1136/bmj.b2535 ID - Moher2009 ER - TY - JOUR AU - Paavonen, J. AU - Naud, P. AU - Salmeron, J. AU - Wheeler, C. M. AU - Chow, S. N. AU - Apter, D. AU - Kitchener, H. AU - Castellsague, X. AU - Teixeira, J. C. AU - Skinner, S. R. PY - 2009 DA - 2009// TI - Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)61248-4 DO - 10.1016/S0140-6736(09)61248-4 ID - Paavonen2009 ER - TY - JOUR AU - Garland, S. M. AU - Hernandez-Avila, M. AU - Wheeler, C. M. AU - Perez, G. AU - Harper, D. M. AU - Leodolter, S. AU - Tang, G. W. AU - Ferris, D. G. AU - Steben, M. AU - Bryan, J. PY - 2007 DA - 2007// TI - Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa061760 DO - 10.1056/NEJMoa061760 ID - Garland2007 ER - TY - JOUR AU - Munoz, N. AU - Manalastas, R. AU - Pitisuttithum, P. AU - Tresukosol, D. AU - Monsonego, J. AU - Ault, K. AU - Clavel, C. AU - Luna, J. AU - Myers, E. AU - Hood, S. PY - 2009 DA - 2009// TI - Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60691-7 DO - 10.1016/S0140-6736(09)60691-7 ID - Munoz2009 ER - TY - JOUR AU - Collins, S. AU - Mazloomzadeh, S. AU - Winter, H. AU - Blomfield, P. AU - Bailey, A. AU - Young, L. S. AU - Woodman, C. B. PY - 2002 DA - 2002// TI - High incidence of cervical human papillomavirus infection in women during their first sexual relationship JO - BJOG VL - 109 UR - https://doi.org/10.1111/j.1471-0528.2002.01053.x DO - 10.1111/j.1471-0528.2002.01053.x ID - Collins2002 ER - TY - JOUR AU - Winer, R. L. AU - Lee, S. K. AU - Hughes, J. P. AU - Adam, D. E. AU - Kiviat, N. B. AU - Koutsky, L. A. PY - 2003 DA - 2003// TI - Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students JO - Am J Epidemiol VL - 157 UR - https://doi.org/10.1093/aje/kwf180 DO - 10.1093/aje/kwf180 ID - Winer2003 ER - TY - JOUR AU - Hildesheim, A. AU - Herrero, R. AU - Wacholder, S. AU - Rodriguez, A. C. AU - Solomon, D. AU - Bratti, M. C. AU - Schiller, J. T. AU - Gonzalez, P. AU - Dubin, G. AU - Porras, C. PY - 2007 DA - 2007// TI - Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial JO - JAMA VL - 298 UR - https://doi.org/10.1001/jama.298.7.743 DO - 10.1001/jama.298.7.743 ID - Hildesheim2007 ER - TY - STD TI - Olsson SE, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, et al: Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin. 2009, 5 (10): 10.4161/hv.5.10.9515. ID - ref22 ER - TY - JOUR AU - Villa, L. L. AU - Costa, R. L. AU - Petta, C. A. AU - Andrade, R. P. AU - Paavonen, J. AU - Iversen, O. E. AU - Olsson, S. E. AU - Hoye, J. AU - Steinwall, M. AU - Riis-Johannessen, G. PY - 2006 DA - 2006// TI - High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up JO - Br J Cancer VL - 95 UR - https://doi.org/10.1038/sj.bjc.6603469 DO - 10.1038/sj.bjc.6603469 ID - Villa2006 ER - TY - JOUR AU - Rowhani-Rahbar, A. AU - Mao, C. AU - Hughes, J. P. AU - Alvarez, F. B. AU - Bryan, J. T. AU - Hawes, S. E. AU - Weiss, N. S. AU - Koutsky, L. A. PY - 2009 DA - 2009// TI - Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine JO - Vaccine VL - 27 UR - https://doi.org/10.1016/j.vaccine.2009.07.027 DO - 10.1016/j.vaccine.2009.07.027 ID - Rowhani-Rahbar2009 ER - TY - JOUR PY - 2007 DA - 2007// TI - Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa061741 DO - 10.1056/NEJMoa061741 ID - ref25 ER - TY - JOUR AU - Garland, S. M. AU - Ault, K. A. AU - Gall, S. A. AU - Paavonen, J. AU - Sings, H. L. AU - Ciprero, K. L. AU - Saah, A. AU - Marino, D. AU - Ryan, D. AU - Radley, D. PY - 2009 DA - 2009// TI - Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials JO - Obstet Gynecol VL - 114 UR - https://doi.org/10.1097/AOG.0b013e3181c2ca21 DO - 10.1097/AOG.0b013e3181c2ca21 ID - Garland2009 ER - TY - STD TI - National Vital Statistics Reports. 2009, Atlanta: Centers for Disease Control and Prevention; National Center for Health Statistics, 58: 15- ID - ref27 ER - TY - JOUR AU - Koutsky, L. A. AU - Ault, K. A. AU - Wheeler, C. M. AU - Brown, D. R. AU - Barr, E. AU - Alvarez, F. B. AU - Chiacchierini, L. M. AU - Jansen, K. U. PY - 2002 DA - 2002// TI - A controlled trial of a human papillomavirus type 16 vaccine JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMoa020586 DO - 10.1056/NEJMoa020586 ID - Koutsky2002 ER - TY - JOUR AU - Mao, C. AU - Koutsky, L. A. AU - Ault, K. A. AU - Wheeler, C. M. AU - Brown, D. R. AU - Wiley, D. J. AU - Alvarez, F. B. AU - Bautista, O. M. AU - Jansen, K. U. AU - Barr, E. PY - 2006 DA - 2006// TI - Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial JO - Obstet Gynecol VL - 107 UR - https://doi.org/10.1097/01.AOG.0000192397.41191.fb DO - 10.1097/01.AOG.0000192397.41191.fb ID - Mao2006 ER - TY - JOUR AU - Villa, L. L. AU - Costa, R. L. AU - Petta, C. A. AU - Andrade, R. P. AU - Ault, K. A. AU - Giuliano, A. R. AU - Wheeler, C. M. AU - Koutsky, L. A. AU - Malm, C. AU - Lehtinen, M. PY - 2005 DA - 2005// TI - Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial JO - Lancet Oncol VL - 6 UR - https://doi.org/10.1016/S1470-2045(05)70101-7 DO - 10.1016/S1470-2045(05)70101-7 ID - Villa2005 ER - TY - JOUR AU - Brown, D. R. AU - Kjaer, S. K. AU - Sigurdsson, K. AU - Iversen, O. E. AU - Hernandez-Avila, M. AU - Wheeler, C. M. AU - Perez, G. AU - Koutsky, L. A. AU - Tay, E. H. AU - Garcia, P. PY - 2009 DA - 2009// TI - The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years JO - The Journal of infectious diseases VL - 199 UR - https://doi.org/10.1086/597307 DO - 10.1086/597307 ID - Brown2009 ER - TY - JOUR AU - Wheeler, C. M. AU - Kjaer, S. K. AU - Sigurdsson, K. AU - Iversen, O. E. AU - Hernandez-Avila, M. AU - Perez, G. AU - Brown, D. R. AU - Koutsky, L. A. AU - Tay, E. H. AU - Garcia, P. PY - 2009 DA - 2009// TI - The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years JO - The Journal of infectious diseases VL - 199 UR - https://doi.org/10.1086/597309 DO - 10.1086/597309 ID - Wheeler2009 ER - TY - JOUR AU - Paavonen, J. AU - Jenkins, D. AU - Bosch, F. X. AU - Naud, P. AU - Salmeron, J. AU - Wheeler, C. M. AU - Chow, S. N. AU - Apter, D. L. AU - Kitchener, H. C. AU - Castellsague, X. PY - 2007 DA - 2007// TI - Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial JO - Lancet VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60946-5 DO - 10.1016/S0140-6736(07)60946-5 ID - Paavonen2007 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/11/13/prepub UR - http://www.biomedcentral.com/1471-2334/11/13/prepub ID - ref34 ER -